EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical and molecular features of early onset pancreatic adenocarcinoma

Maxime Rémond iD, Cristina Smolenschi, Anthony Tarabay, Maximiliano Gelli, Elena Fernandez-de-Sevilla, Ali Mouawia, Simona Cosconea, Lambros Tselikas, Remy Barbe, Alina Fuerea, Mohamed A Bani, Marc Deloger und 7 weitere

International Journal of Cancer · 2024-12 · 155 (11) · 1969-1981

DOI: 10.1002/ijc.35135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 15.08.2024. Verfasst von Maxime Rémond und 18 weiteren Autor:innen. Beteiligte Einrichtung: Département de Médecine, Gustave Roussy, Villejuif, France. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic adenocarcinoma (PDAC) is a major health burden and may become the second cause of death by cancer in developed countries. The incidence of early‐onset pancreatic cancer (EOPC, defined by an age at diagnosis 50). Eight hundred and seventy eight patients were included, of which 113 EOPC, exhibiting a comparable performance status. EOPC were more often diagnosed at the metastatic stage (70.0% vs 58.3%) and liver metastases were more prevalent at diagnosis (60.2% vs. 43.9%). The median overall survival (OS) from diagnosis was 18.1 months, similar between EOPC and nEOPC. Among patients who underwent surgery, recurrence‐free survival was similar between age groups. Among metastatic patients, first line progression free survival was similar but EOPC received more treatment lines (72.3% vs. 58.1% received ≥2 lines). Regarding molecular alterations, the mean tumor mutational burden (TMB) was lower in EOPC (1.42 vs. 2.95 mut/Mb). The prevalence of KRAS and BRCA1/2 mutations was similar, but EOPC displayed fewer alterations in CNKN2A/B. Fifty eight patients (18.6%) had actionable alterations (ESCAT I‐III) and 31 of them received molecularly matched treatments. On the transcriptomic level, despite its clinical aggressiveness, EOPC was less likely to display a basal‐like phenotype. To conclude, EOPC were diagnosed more frequently at the metastatic stage. OS and 1st line PFS were similar to nEOPC. EOPC displayed specific molecular features, such as a lower TMB and fewer alterations in CDKN2A/B.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsHumansMaleFemaleMiddle AgedAdultAge of OnsetAgedAdenocarcinomaMutationBiomarkers, TumorLiver Neoplasms

Stichwörter der Autor:innen

early‐onsetpancreatic adenocarcinomapancreatic cancerprecision medicinetranscriptomic

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Département de Médecine, Gustave Roussy, Villejuif, France.
  • Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Villejuif, France.
  • Département de Chirurgie, Gustave Roussy, Villejuif, France.
  • Département d'Endoscopie, Gustave Roussy, Villejuif, France.
  • Département de Radiologie Interventionnelle, Gustave Roussy, Villejuif, France.
  • Département d'Imagerie, Gustave Roussy, Villejuif, France.

ORCID-Profile: Maxime Rémond

Zitieren

APA

Rémond, M., Smolenschi, C., Tarabay, A., Gelli, M., Fernandez-de-Sevilla, E., Mouawia, A., Cosconea, S., Tselikas, L., Barbe, R., Fuerea, A., Bani, M. A., Deloger, M., Besse, B., Pudlarz, T., Valéry, M., Boige, V., Hollebecque, A., Ducreux, M., & Boilève, A. (2024). Clinical and molecular features of early onset pancreatic adenocarcinoma. International Journal of Cancer, 155(11), 1969-1981. https://doi.org/10.1002/ijc.35135

Vancouver

Rémond M, Smolenschi C, Tarabay A, Gelli M, Fernandez-de-Sevilla E, Mouawia A, et al. Clinical and molecular features of early onset pancreatic adenocarcinoma. International Journal of Cancer. 2024;155(11):1969-1981. doi:10.1002/ijc.35135

BibTeX
@article{Rmond2024,
  author = {Rémond, Maxime and Smolenschi, Cristina and Tarabay, Anthony and Gelli, Maximiliano and Fernandez-de-Sevilla, Elena and Mouawia, Ali and Cosconea, Simona and Tselikas, Lambros and Barbe, Remy and Fuerea, Alina and Bani, Mohamed A and Deloger, Marc and Besse, Benjamin and Pudlarz, Thomas and Valéry, Marine and Boige, Valérie and Hollebecque, Antoine and Ducreux, Michel and Boilève, Alice},
  title = {Clinical and molecular features of early onset pancreatic adenocarcinoma},
  journal = {International Journal of Cancer},
  year = {2024},
  volume = {155},
  number = {11},
  pages = {1969--1981},
  doi = {10.1002/ijc.35135}
}
Kostenlos starten →